Health Care/Hospital

Rznomics Granted Orphan Medicinal Product Designation for RZ-001 for the Treatment of Glioma by the European Commission

SEONGNAM, South Korea, Oct. 22, 2026 /PRNewswire/ -- Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced today that the European Commission (EC) has granted Orphan Medicinal Product Designation to 'taspitimagene advec(RZ-001)', its RNA...

2026-10-22 13:30 2046

NUH WINS GOLD AT IHF AWARDS 2026 FOR GREEN OPERATING THEATRE PROGRAMME

 NUH won Gold and received an Honourable Mention for its sustainability efforts at the International Hospital Federation Awards 2026, alongside presentations of its green surgical initiatives, digital health and organisational improvement initiatives at the World Hospital Congress. SINGAPORE, Oc...

2026-10-22 09:27 5561

Taimei Technology and GreenLight Clinical Expand Strategic Partnership at AusBiotech 2026 to Pioneer AI-Native Trial Execution Across Asia-Pacific

GOLD COAST, Australia, Oct. 22, 2026 /PRNewswire/ -- Taimei Technology, a global provider of AI-powered clinical development platforms, and GreenLight Clinical (GLC), a physician-led contract research organization (CRO), today announced an expanded strategic partnership at AusBiotech 2026. Evolvi...

2026-10-22 08:00 4654

Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids

DUBLIN, Oct. 22, 2026 /PRNewswire/ -- Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced today that its THERAKOS™ CELLEX™ Photopheresis System has received certification under the EU MDR for an ...

2026-10-22 02:01 2973

Geneos Therapeutics Initiates IMPACT31 Phase 2 Randomized Clinical Trial Evaluating Neoantigen-Targeted Personalized DNA Immunotherapy for Cancer

* The study evaluates patients with liver cancer at high risk of recurrence following surgical resection * Julie Rosenberg, MD, appointed to leadership team as Chief Medical Officer PHILADELPHIA, Oct. 21, 2026 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focus...

2026-10-21 21:10 4427

Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer

* Becomes the 7th International Registrational Clinical Trial for Ivonescimab * Clinical Trial Site Activations in the United States Expected to Begin Q4 2026 HONG KONG, Oct. 21, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced that Summit Therapeutics Inc. (NASDAQ: SMMT), its ...

2026-10-21 20:42 2289

Axtria Wins 2026 Minsky Award for Excellence in AI for the Third Consecutive Year

AI-powered Next Best Action solution generated more than $180 million in incremental revenue for a brand for a global pharmaceutical leader BERKELEY HEIGHTS, N.J., Oct. 21, 2026 /PRNewswire/ -- Axtria Inc.

2026-10-21 20:15 1930

China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right

TAIZHOU, China, Oct. 21, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"),today announced that it has entered into a termination letter agreement with the purchasers in its registered direct offering announced on October 8, 2026 (the "Offering"). Under the termi...

2026-10-21 20:00 4014

Manulife and UpLink announce winners of the 'Shaping Canada's Longevity Advantage' Challenge

Ten innovators selected for solutions that help Canadians live longer, healthier, more financially secure lives The challenge is an initiative of Manulife's Longevity Institute, driving solutions for a longer‑living Canadian society TORONTO, Oct. 21, 2026 /PRNewswire/ -- Manulife, in collaborat...

2026-10-21 20:00 4384

ESTEVE CDMO expands its presence in Asia with a major investment and new manufacturing site in China

* After more than two decades in China, ESTEVE CDMO marks a new chapter in its commitment to the country and the region. * With more than $80 million invested, the new facility brings a new generation of manufacturing capabilities, with 250 m³ of reaction volume and potential capacity of more...

2026-10-21 18:41 3908

HelpMeSee Guwahati Training Operation Reaches 51 Ophthalmologists Across Northeast India

Successful collaboration with HMS Vision Private Limited and Sri Sankaradeva Nethralaya expands access to simulation-based cataract surgical training across four Northeast states GUWAHATI, India, Oct. 21, 2026 /PRNewswire/ -- HelpMeSee and HMS Vision Private Limited, in collaboration with Sri Sa...

2026-10-21 18:30 1394

Chen Qiyu: Building on "Affordability & Reliability", Fosun Expands the Global Reach of Chinese Innovative Drugs

HONG KONG, Oct. 21, 2026 /PRNewswire/ -- On 20 October, the Sustainability Global Leaders Conference 2026 was held in Shanghai. The Conference, themed "Building a Resilient Future Together: Global Governance, Innovation-Driven Growth, and Industrial Upgrading", brought together more than 300 gues...

2026-10-21 16:52 3504

CSL appoints Deborah Waterhouse as CEO & Managing Director

MELBOURNE, Australia, Oct. 21, 2026 /PRNewswire/ -- The Board of Directors of CSL Limited (ASX:CSL; USOTC:CSLLY) today announces that it has appointed Deborah Waterhouse as Chief Executive Officer and Managing Director of CSL from 1 February 2027. The appointment was made following an extensive g...

2026-10-21 15:56 4519

Samsung Biologics Reports Third Quarter 2026 Financial Results

* Recorded Q3'26 revenue of KRW 1,490 billion and operating profit of KRW 640 billion * Plant 5 ramp-up and U.S. manufacturing operations contribute to earnings performance * Raised 2026 revenue growth guidance to 20% while advancing strategic investments in portfolio and capacity expansion...

2026-10-21 15:00 3478

Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical Value

* 64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and supportive care. * More than 10 studies have been selected to highlight the latest findings on HER2- and HER3-targeted anti...

2026-10-21 10:09 1793

Hanwha Life Invitational Brings Together Rising Women's Golf Talent from Six Asian Countries

Inaugural tournament concludes in South Korea, creating opportunities for young golfers to compete and gain international experience * Yoonju Ahn of South Korea wins the inaugural title at 11-under-par 205. * Junior golfers from South Korea, Vietnam, Indonesia, Thailand, Malaysia and Singapor...

2026-10-21 09:47 4190

Homage Launches Esteem AI to Meet Surging Eldercare Demand Across Asia

AI agents prepare the paperwork behind every care visit. Care teams stay in control of the care. SINGAPORE, Oct. 21, 2026 /PRNewswire/ -- Homage , the Singapore-foundedhome care company, today launchedEsteem AI

2026-10-21 09:00 3037

AROA and Mölnlycke Partner to Expand U.S. Access to Endoform™

Exclusive co-promotion agreement combines AROA's regenerative tissue technology with Mölnlycke's wound care expertise and commercial reach AUCKLAND, New Zealand, Oct. 20, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, has entered into an exclusive ag...

2026-10-21 08:00 2201

Telix Reports Third Quarter 2026 Financial Performance

MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026). Q3 2026 Highlights[1] * Group reven...

2026-10-21 06:08 4954

Lunit Highlights AI-Powered Pathology Insights Across Cancer Types at ESMO 2026

Five studies to be presented, with key research examining AI-based biomarker assessment and tumor microenvironment analysis in breast, lung and pancreatic cancers SEOUL, South Korea, Oct. 20, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision ...

2026-10-20 21:00 2732
1234567 ... 845